Smoking, Respiratory Issues, Older Age Raise Hospital Costs, Chinese Study Finds
Older age, smoking, and having other respiratory symptoms and conditions increase the hospitalization costs of people with...
Microbe DNA Discovery May Lead to Noninvasive Test for CF Infections
People with cystic fibrosis (CF) have higher levels of DNA from common microbes that cause CF-related infections circulating in their...
Researchers Develop Promising Antibiotic Molecule for Drug-resistant Lung Infections
A man-made antibiotic able to fight drug-resistant bacteria in the lungs with minimal toxicity to a person’s cells may be a promising...
CF Newborn Screening Improves Weight and Lung Outcomes, but Has No Impact on Social Inequalities, St
Babies diagnosed with cystic fibrosis (CF) through newborn bloodspot screening show better lung function, can better stave off infection...
Murepavadin Antibiotic Well-tolerated by Animals Infected with Pseudomonas Aeruginosa, Preclinical D
Murepavadin (POL7080), Polyphor‘s lead investigational antibiotic targeting Gram-negative bacteria, behaved as expected and was...
New Approach Against Antibiotic-resistant Bacteria in CF Patients Shows Promise in Phase 1 Trial
Researchers may have found a new way of treating antibiotic-resistant bacterial infections, specifically Pseudomonas aeruginosa, in the...
AIT’s Inhaled Nitric Oxide Shows Potential in Fighting Bacterial Infection Prevalent in CF Patients
Inhaled nitric oxide (NO) was shown to be an effective antibacterial agent against Mycobacterium abscessus infection in preclinical...
New Method to Deliver Bacteria-killing Viruses Seen to Resolve Lung Infections in CF Mice
A new therapy which is administered directly into the lung of viruses can kill bacteria, and was shown to be effective in reducing...
P. aeruginosa Infection Differs Between Cystic Fibrosis and Non-CF Bronchiectasis, Study Shows
Pseudomonas aeruginosa, one of the most common types of bacteria present in severe lung infections, infects cystic fibrosis (CF) patients...
Azithromycin Reduced Pulmonary Exacerbation Risk in Cystic Fibrosis
Azithromycin significantly reduced the risk for pulmonary exacerbations and resulted in sustained improvement in weight but had no effect...
